T-helper (Th) cells play an important role in orchestrating the effector function of CTL in anti-tumor immunity. However, only a limited number of Th cell epitopes has been characterized. Here we describe a novel approach for identifying naturally processed and presented peptides derived from chosen antigens. This method combines a transfection step of antigen-presenting cells with a vector encoding a fusion protein between the li chain and the antigen of interest, elution of the HLA-bound peptides and identification of the antigen-derived peptides by mass spectrometric comparison to the non-transfected cells. In vitro-stimulated Th cells against the identified peptide of interest specifically recognize transfectants overexpressing the cognate antigen. Using this approach, we were able to identify the HLA-DR4-restricted Th cell epitope NPPSMVAAGSVVAAV derived from cyclin D1, which is frequently overexpressed in tumors. This method will help in identifying peptide candidates for vaccination studies for tumor immunotherapy. © 2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
CITATION STYLE
Dengjel, J., Decker, P., Schoor, O., Altenberend, F., Weinschenk, T., Rammensee, H. G., & Stevanovic, S. (2004). Identification of a naturally processed cyclin D1 T-helper epitope by a novel combination of HLA class II targeting and differential mass spectrometry. European Journal of Immunology, 34(12), 3644–3651. https://doi.org/10.1002/eji.200425510
Mendeley helps you to discover research relevant for your work.